In the end, compounds 86 and 87, which were recognized by exploration of ER degradation and antagonism in vitro followed by in vivo antagonism and culminating in oral exposure, could induce tumor regression inside of a tamoxifen-resistant breast cancer xenograft. Regardless of the different profiles of SC abuse, due to the fact these substances